Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 201

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 201
---
 CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. The business address of Valetudo Therapeutics LLC is 2064 Christie St., Fullerton, CA 92833. |

| (2) | Consists of shares of Common Stock held of record by KH Feelux Co., Ltd. KH Feelux Co., Ltd is a company formed in the Republic of Korea. The business address of Feelux is 2F, Jbuilding , 32, Eonji-ro, 71-gil, Gangnam-gu, Seoul, 06226, Republic of Korea. Feelux is a publicly traded company in Korea. |

| (3) | Consists of shares of Common Stock held of record by Iris Acquisition Holdings LLC. The business address of Iris Acquisition Holdings LLC is 3rd Floor Zephyr House, 122 Mary Street, George Town, PO Box 10085, Grand Cayman KY1-1001, Cayman Islands. Iris Equity Holdings LLC is the managing member of Iris Acquisition Holdings LLC  and is controlled by Gaius Investment Partners Co Ltd. The natural persons who have voting and/or investment power over the shares held by the Sponsor are Joon Seok Yoo and Joon Young Yoo. |

128

| (4) | Consists of shares of Common Stock held of record by Ewon Comfortech Co., Ltd. The business address of Ewon Comfortech Co., Ltd. is 8 Cheomdan 1-ro Jeongeup-si, Jeonbuk-do, 56212 Republic of South Korea. Ewon Comfortech is a publicly traded company in Korea. |

| (5) | Consists of (i) 835,555 shares of Common Stock issuable upon the exercise of Private Warrants and (ii) up to (ii) 700,000 shares of Common Stock issued to Cantor in settlement of $7.0 million in deferred underwriting fees. Cantor Fitzgerald & Co. (“CF&CO”) is the record owner of the securities reported herein. The business address of CF&CO is 110 East 59th Street, New York, NY 10022. Cantor Fitzgerald Securities (“CFS”) controls the managing general partner of CF&CO. Cantor Fitzgerald, L.P. (“CFLP”) indirectly controls each of CFS and CF&CO. CFLP is controlled